insights_auto
Why is NWBO down 5.21%?
Dive Deeperchevron_right
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
$0.16
arrow_downward
-5.21%(-0.0086) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NWBO...
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
259.24M
Avg. vol.
5.32M
Volume
4.71M
52-wk high
$0.34
52-wk low
$0.14
EPS
-$0.03
Beta
-0.59
Shares outstanding
1.71B
No. of employees
105
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
259.24M
Avg. vol.
5.32M
Volume
4.71M
52-wk high
$0.34
52-wk low
$0.14
EPS
-$0.03
Beta
-0.59
Shares outstanding
1.71B
No. of employees
105
News stories
From web sources and news partners
Reuters
·
17 hours ago
S&P 500, Nasdaq end lower as Nvidia uncertainty weighs on tech shares
marketscreener.com
·
6 hours ago
S&P 500 Posts Weekly Gain as Energy Sector Leads Broad Climb
qz.com
·
6 hours ago
How much of the S&P 500 is Nvidia? Concentration explained
Investing.com
·
6 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.10%
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc
CEO-
Employees105
FoundedJan 1, 1998
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitenwbio.com